U.S. Markets open in 6 hrs 45 mins

MetLife, Inc. (MET)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
38.72+1.74 (+4.71%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close36.98
Open36.92
Bid0.00 x 1000
Ask0.00 x 900
Day's Range36.57 - 38.92
52 Week Range22.85 - 53.28
Volume8,486,435
Avg. Volume6,125,387
Market Cap35.142B
Beta (5Y Monthly)1.34
PE Ratio (TTM)5.02
EPS (TTM)7.71
Earnings DateOct 28, 2020 - Nov 02, 2020
Forward Dividend & Yield1.84 (4.75%)
Ex-Dividend DateAug 03, 2020
1y Target Est44.00
  • Barrons.com

    Thoma Bravo Raises Offer for Insurtech Majesco to $729 Million. Here’s Why.

    An unsolicited bid has spurred Thoma Bravo to boost the price it is paying for (MJCO) by 22%. The technology-focused private-equity firm said Saturday that it had amended its agreement to acquire the insurtech company. Thoma Bravo is now paying $16 a share, or $729 million, for Majesco (ticker: MJCO), according to a statement.

  • MetLife Foundation Commits $500,000 to Lebanon Relief Effort
    Business Wire

    MetLife Foundation Commits $500,000 to Lebanon Relief Effort

    MetLife Foundation announced today a commitment of $500,000 to help Lebanon recover and rebuild from the Beirut port explosion.

  • Benzinga

    Price Over Earnings Overview: MetLife

    Right now, MetLife Inc. (NYSE: MET) share price is at $37.16, after a 3.03% drop. Over the past month, the stock increased by 5.00%, but over the past year, it actually fell by 20.78%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.The stock is currently higher from its 52 week low by 62.63%. Assuming that all other factors are held constant, this could present itself as an opportunity for investors trying to diversify their portfolio with Insurance--Life stocks, and capitalize on the lower share price observed over the year.The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against its past earnings, historical data and aggregate market data for the industry or the indices, such as S&P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also shows that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future.View more earnings on METDepending on the particular phase of a business cycle, some industries will perform better than others.MetLife Inc. has a lower P/E than the aggregate P/E of 9.79 of the Insurance--Life industry. Ideally, one might believe that they might perform worse than its peers, but it's also probable that the stock is undervalued.Price to earnings ratio is not always a great indicator of the company's performance. Depending on the earnings makeup of a company, investors may not be able to attain key insights from trailing earnings.See more from Benzinga * P/E Ratio Insights for e.l.f. Beauty * Price Over Earnings Overview: GoDaddy * A Look Into Zynga's Price Over Earnings(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.